A detailed history of Investment House LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Investment House LLC holds 689 shares of REGN stock, worth $508,482. This represents 0.04% of its overall portfolio holdings.

Number of Shares
689
Previous 699 1.43%
Holding current value
$508,482
Previous $734,000 1.36%
% of portfolio
0.04%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$1024.09 - $1201.76 $10,240 - $12,017
-10 Reduced 1.43%
689 $724,000
Q4 2023

Feb 05, 2024

SELL
$775.18 - $881.7 $12,402 - $14,107
-16 Reduced 2.24%
699 $613,000
Q3 2023

Nov 09, 2023

SELL
$692.45 - $844.37 $311,602 - $379,966
-450 Reduced 38.63%
715 $588,000
Q3 2022

Oct 31, 2022

SELL
$573.97 - $724.32 $17,219 - $21,729
-30 Reduced 2.51%
1,165 $803,000
Q2 2020

Jul 13, 2020

SELL
$493.32 - $643.92 $7,399 - $9,658
-15 Reduced 1.24%
1,195 $745,000
Q1 2020

Apr 08, 2020

BUY
$336.18 - $494.43 $10,085 - $14,832
30 Added 2.54%
1,210 $591,000
Q4 2019

Feb 05, 2020

SELL
$274.13 - $376.51 $13,706 - $18,825
-50 Reduced 4.07%
1,180 $443,000
Q3 2019

Nov 12, 2019

SELL
$273.46 - $318.39 $197,711 - $230,195
-723 Reduced 37.02%
1,230 $341,000
Q2 2019

Aug 05, 2019

SELL
$299.6 - $414.82 $17,976 - $24,889
-60 Reduced 2.98%
1,953 $611,000
Q1 2019

May 03, 2019

BUY
$372.08 - $439.57 $66,974 - $79,122
180 Added 9.82%
2,013 $827,000
Q4 2018

Feb 06, 2019

SELL
$335.82 - $403.04 $35,261 - $42,319
-105 Reduced 5.42%
1,833 $685,000
Q3 2018

Oct 09, 2018

SELL
$351.14 - $408.51 $1,755 - $2,042
-5 Reduced 0.26%
1,938 $783,000
Q2 2018

Jul 10, 2018

SELL
$284.6 - $344.99 $129,493 - $156,970
-455 Reduced 18.97%
1,943 $670,000
Q1 2018

May 08, 2018

BUY
$315.82 - $393.78 $757,336 - $944,284
2,398 New
2,398 $826,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Investment House LLC Portfolio

Follow Investment House LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment House LLC with notifications on news.